Evolent Health Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results. Also, Truist Securities Upgraded the Stock From Hold to Buy and Raised Its Price Target From $28 to $33.
Evolent Health Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results. Also, Truist Securities Upgraded the Stock From Hold to Buy and Raised Its Price Target From $28 to $33.
evolent health股票在公司公佈了超預期的Q2業績後交易上漲，此外，Truist證券將該股票評級從持有升級爲買入，並將其目標價格從28美元上調至33美元。
Evolent Health Shares Are Trading Higher After the Company Reported Better-than-expected Q2 Financial Results. Also, Truist Securities Upgraded the Stock From Hold to Buy and Raised Its Price Target From $28 to $33.
evolent health股票在公司公佈了超預期的Q2業績後交易上漲，此外，Truist證券將該股票評級從持有升級爲買入，並將其目標價格從28美元上調至33美元。
資訊熱榜
更新時間